| 注册
首页|期刊导航|肿瘤预防与治疗|放疗联合免疫治疗在局部晚期不可切除食管癌中的研究进展

放疗联合免疫治疗在局部晚期不可切除食管癌中的研究进展

谢良云 张志

肿瘤预防与治疗2024,Vol.37Issue(12):1076-1083,8.
肿瘤预防与治疗2024,Vol.37Issue(12):1076-1083,8.DOI:10.3969/j.issn.1674-0904.2024.12.009

放疗联合免疫治疗在局部晚期不可切除食管癌中的研究进展

Research Progress of Radiotherapy Combined with Immunotherapy in the Treatment of Locally Advanced Unresectable Esophageal Cancer

谢良云 1张志2

作者信息

  • 1. 050017 石家庄,河北医科大学研究生学院||063003 河北唐山,河北医科大学附属唐山市工人医院肿瘤内科
  • 2. 063003 河北唐山,河北医科大学附属唐山市工人医院肿瘤内科
  • 折叠

摘要

Abstract

With the emergence of immunotherapy,the treatment of esophageal cancer has been undergoing a profound transformation.Currently,immunotherapy is recommended as the first-line therapy for advanced esophageal cancer.However,for patients with locally advanced and unresectable esophageal cancer,the current standard treatment remains radical radio-therapy combined with chemotherapy,often resulting in unfavorable prognosis.Nevertheless,accumulating evidence suggests that the combination of radiotherapy and immunotherapy can yield synergistic effects.This article aims to comprehensively re-view the underlying mechanisms of this combined approach and its clinical applications in the management of locally ad-vanced and unresectable esophageal cancer.

关键词

食管癌/放疗/免疫治疗/局部晚期/不可切除/研究进展

Key words

Esophageal cancer/Radiotherapy/Immunotherapy/Locally advanced/Unresectable/Research progress

分类

医药卫生

引用本文复制引用

谢良云,张志..放疗联合免疫治疗在局部晚期不可切除食管癌中的研究进展[J].肿瘤预防与治疗,2024,37(12):1076-1083,8.

基金项目

This study was supported by Natural Science Foundation of Hebei Province(No.H2023105018). 河北省自然科学基金(编号:H2023105018) (No.H2023105018)

肿瘤预防与治疗

OACSTPCD

1674-0904

访问量0
|
下载量0
段落导航相关论文